Inactive Instrument
Albany Molecular Research, Inc. Stock
Stocks
US0124231095
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Philip Macnabb
CEO | Chief Executive Officer | - | 2023-02-28 |
Gerald Auer
DFI | Director of Finance/CFO | - | 2023-12-31 |
John Valley
CTO | Chief Tech/Sci/R&D Officer | - | 2019-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +0.09% | - | - | 0 | ||
| +0.82% | +1.47% | +0.35% | +15.84% | 48.53B | ||
| -2.06% | -0.90% | +411.96% | +472.09% | 39.87B | ||
| -0.61% | +12.96% | +28.81% | +7.27% | 38.68B | ||
| -0.94% | -3.03% | +5.69% | +66.52% | 35.13B | ||
| -1.74% | +5.12% | +14.44% | +44.64% | 29.79B | ||
| -0.39% | -4.04% | +36.40% | +126.06% | 16.11B | ||
| -0.89% | -3.92% | - | - | 16.08B | ||
| +1.41% | +2.72% | +3.31% | +16.75% | 13.61B | ||
| -1.05% | -1.32% | -1.73% | -34.97% | 12.62B | ||
| Average | -0.78% | +1.05% | +62.40% | +89.27% | 27.82B | |
| Weighted average by Cap. | -0.79% | +2.03% | +80.20% | +108.20% |
















